PRTFDC1
Phosphoribosyltransferase domain-containing protein 1
Also known as: HHGP, PRDC1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NRG1
- Gene
- PRTFDC1
- Ensembl
- ENSG00000099256
- Chromosome
- 10
- Canonical length
- 225 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables protein homodimerization activity. Predicted to be involved in purine ribonucleoside salvage. Predicted to be active in cytosol. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
225 residues, UniProt reviewed canonical sequence.
>Q9NRG1|PRTFDC1
1 MAGSSEEAPD YGRGVVIMDD WPGYDLNLFT YPQHYYGDLE YVLIPHGIIV DRIERLAKDI
61 MKDIGYSDIM VLCVLKGGYK FCADLVEHLK NISRNSDRFV SMKVDFIRLK SYRNDQSMGE
121 MQIIGGDDLS TLAGKNVLIV EDVVGTGRTM KALLSNIEKY KPNMIKVASL LVKRTSRSDG
181 FRPDYAGFEI PNLFVVGYAL DYNEYFRDLN HICVINEHGK EKYRVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRTFDC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 34 nTPM
- midbrain: 28 nTPM
- basal ganglia: 26 nTPM
- cerebral cortex: 26 nTPM
- amygdala: 25 nTPM
- ovary: 24 nTPM
Single-cell type
- astrocytes: 140 nCPM
- oligodendrocytes: 140 nCPM
- bergmann glia: 134 nCPM
- ependymal cells: 127 nCPM
- platelets: 108 nCPM
- oligodendrocyte progenitor cells: 105 nCPM
Immune cell
- NK-cell: 4.5 nTPM
- total PBMC: 0.9 nTPM
- MAIT T-cell: 0.5 nTPM
- gdT-cell: 0.2 nTPM
- memory CD4 T-cell: 0.2 nTPM
- memory CD8 T-cell: 0.2 nTPM
Brain region
- white matter: 61 nTPM
- basal ganglia: 44 nTPM
- medulla oblongata: 43 nTPM
- spinal cord: 39 nTPM
- hypothalamus: 37 nTPM
- cerebellum: 37 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.69
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.44
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PRTFDC1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRTFDC1 as an antibody target. Whether an autoantibody or antibody against PRTFDC1 could matter depends on whether native PRTFDC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRTFDC1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PRTFDC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...